Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative analysis of parenteral opioids for acute sickle cell pain crisis at Korle Bu Polyclinic
PACTR201812917283565Completed
- Sponsor
- 7 Hills Pharma
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of pethidine and morphine in sickle cell disease (SCD) (2 arms), sponsored by 7 Hills Pharma. Primary endpoint: Sustained pain reduction within 72 hours. Started Nov 2016; status: completed.
02
Drugs
pethidinemorphine
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on PACTR201812917283565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201812917283565.